/DaVita%20Inc%20sign%20on%20building-by%20photo-denver%20via%20Shutterstock.jpg)
With a market cap of $13.5 billion, DaVita Inc. (DVA) is a leading provider of dialysis services in the U.S., specializing in the care of patients with chronic kidney failure or end-stage renal disease (ESRD). It operates kidney dialysis centers and offers a comprehensive range of services, including outpatient and inpatient dialysis, related laboratory testing, disease management, and integrated care solutions. The Denver, Colorado-based is expected to announce its fiscal Q4 earnings results on Tuesday, Feb. 11.
Ahead of this event, analysts expect the dialysis specialist to report a profit of $2.21 per share, up 18.2% from $1.87 per share in the year-ago quarter. The company has surpassed Wall Street's earnings estimates in three of the last four quarters while missing on another occasion. In Q3, DVA missed the consensus EPS estimate by 6.2%.
